Black Rock Inc. Geron Corp Put Options Transaction History
Black Rock Inc.
- $4.35 Trillion
- Q2 2024
Put Options
0 transactions
Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
---|
Others Institutions Holding GERN
# of Institutions
295Shares Held
496MCall Options Held
799KPut Options Held
463K-
Ra Capital Management, L.P. Boston, MA60.4MShares$86.3 Million1.99% of portfolio
-
Deep Track Capital, LP Greenwich, CT38.2MShares$54.6 Million2.12% of portfolio
-
Vanguard Group Inc Valley Forge, PA34.1MShares$48.8 Million0.0% of portfolio
-
Vivo Capital, LLC Palo Alto, CA27.2MShares$38.9 Million11.75% of portfolio
-
State Street Corp Boston, MA23.9MShares$34.2 Million0.0% of portfolio
About GERON CORP
- Ticker GERN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 377,819,008
- Market Cap $540M
- Description
- Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...